These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19011857)

  • 1. Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.
    Momiyama K; Nagai H; Sumino Y
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):271-7. PubMed ID: 19011857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy.
    Nagai H; Miyaki D; Matsui T; Kanayama M; Higami K; Momiyama K; Ikehara T; Watanabe M; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):959-63. PubMed ID: 18259753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma.
    Kanayama M; Nagai H; Sumino Y
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):109-14. PubMed ID: 18979100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of etiology on host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy.
    Nagai H; Mukozu T; Kanekawa T; Matsui T; Kanayama M; Wakui N; Momiyama K; Ishii K; Igarashi Y; Sumino Y
    Hepatogastroenterology; 2013 Jun; 60(124):858-63. PubMed ID: 23732780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host Immunity Influences the Efficacy of Combined Intra-Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in Liver Cirrhosis Patients.
    Nagai H; Mukouzu T; Matsui D; Kanekawa T; Matsui T; Kanayama M; Wakui N; Momiyama K; Shinohara M; Ishii K; Igarashi Y; Sumino Y
    Hepatogastroenterology; 2014 May; 61(131):741-6. PubMed ID: 26176067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of cytokines in cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy.
    Nagai H; Miyaki D; Matsui T; Kanayama M; Higami K; Momiyama K; Ikehara T; Watanabe M; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):271-6. PubMed ID: 17899083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T; Nagai H; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal therapy for liver cirrhosis patients with advanced hepatocellular carcinoma.
    Nagai H; Matsui T; Kanayama M; Wakui N; Momiyama K; Watanabe M; Igarashi Y; Sumino Y
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):139-45. PubMed ID: 20857114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
    J Gastroenterol; 2005 Jan; 40(1):70-8. PubMed ID: 15692792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel intrahepatic arterial chemotherapy after radical resection for advanced hepatocellular carcinoma.
    Tanaka S; Shimada M; Shirabe K; Maehara S; Harimoto N; Tsujita E; Sugimachi K; Maehara Y
    Hepatogastroenterology; 2005; 52(63):862-5. PubMed ID: 15966221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
    Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
    J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
    Kanekawa T; Nagai H; Kanayama M; Sumino Y
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatocellular carcinoma using arterial chemoembolization with degradable starch microspheres and continuous arterial infusion of 5-fluorouracil.
    Ishida K; Hirooka M; Hiraoka A; Kumagi T; Uehara T; Hiasa Y; Horiike N; Onji M
    Jpn J Clin Oncol; 2008 Sep; 38(9):596-603. PubMed ID: 18772170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of hepatic arterial infusion therapy for advanced hepatocellular carcinoma according to extrahepatic collateral feeding vessels].
    Jang BK; Chung WJ; Park KS; Cho KB; Hwang JS; Ahn SH; Kim YH; Choi JS; Kwon JH
    Korean J Hepatol; 2005 Dec; 11(4):359-70. PubMed ID: 16380665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of epirubicin and etoposide combination chemotherapy in advanced hepatocellular carcinoma: a retrospective analysis.
    Lee JL; Ryu MH; Chang HM; Kim TW; Lee SS; Sym SJ; Kim MK; Kim KM; Lee JS; Kang YK
    J Gastroenterol Hepatol; 2008 May; 23(5):811-6. PubMed ID: 17995941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
    Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
    Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma.
    Nagai H; Matsui T; Kanayama M; Momiyama K; Shizawa K; Wakui N; Shinohara M; Watanabe M; Iida K; Ishii K; Igarashi Y; Sumino Y
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1123-9. PubMed ID: 20180123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.